Compliance Investigations & White Collar


Lampert to Present CLE Program, Bushwack to be Panelist
November 16, 2020 | Compliance Investigations & White Collar
On December 2, 2020, Matthew Lampert, along with the Chair of the NCBA’s Plaintiff’s  Personal Injury Committee, will be jointly presenting a CLE Program entitled “Why Civility in the Practice of Law Matters.” It will be held over Zoom from 5:30 to 7:30 P.M.  This will be a free CLE program. The format for the …
Read More
Kaiser Quoted on Hospital’s $50M Stark Settlement
November 6, 2020 | Compliance Investigations & White Collar | Health Services
Geoffrey R. Kaiser was quoted in the Healthcare Risk Management article, “$50 Million Stark Settlement Shows Risk of Violation, Whistleblowers.” A West Virginia hospital settled U.S. Department of Justice allegations that it violated the Stark Law and the Anti-Kickback Statute by excessively compensating referring physicians. Jeff noted, “…a hospital may not pay excessive compensation to its …
Read More
Rivkin Radler Attorneys Named As 2020 New York Metro Super Lawyers
October 28, 2020 | Construction | Professional Liability | Real Estate, Zoning & Land Use | Trusts & Estates | Compliance Investigations & White Collar | Appeals | Bankruptcy | Commercial Litigation | Employment & Labor | General Liability | Health Services | Insurance Coverage | Medical Malpractice Defense
UNIONDALE, NY – Rivkin Radler LLP is pleased to announce that 23 attorneys were named to the 2020 New York Metro Super Lawyers List and 13 attorneys were named 2020 New York Metro Rising Stars. Following is a list of attorneys, the practice areas for which they were recognized, and the years they were included …
Read More
Ullman Quoted on FDA Warning Letters
October 23, 2020 | Compliance Investigations & White Collar
Marc Ullman was cited in the NutraIngredients-USA article, “FDA takes aim at claims for infant food allergy prevention.” Two companies have received warning letters from the FDA for claiming that their products can prevent young children from developing certain food allergies. Marc states that the companies can petition the FDA for a broadening of the …
Read More
Ullman Quoted on Sentencing of Supplement-Maker Execs
| Compliance Investigations & White Collar
Marc Ullman spoke to Natural Products Insider for the story, “Execs of once-thriving supplements brand USPlabs sentenced to prison.” USPlabs’ product, OxyElitePro, was implicated in dozens of cases of liver injuries. In 2015, the company and its contract manufacturer were indicted along with USPlabs’ executives who defended the charges for years. Marc noted that FDA-regulated …
Read More
Kaiser to Speak at PLI Life Sciences Program
October 6, 2020 | Compliance Investigations & White Collar | Health Services
On October 13, Jeff Kaiser will be speaking at the Life Sciences 2020: Navigating Legal Challenges in Drug and Device Industries. Jeff will be speaking on the topic of, “Enforcement Trends impacting the Drug and Device Industries” focusing on the following areas: False Claims Act Anti-Kickback Statute Off-label promotion Individual liability Click here to register. …
Read More
6 Rivkin Radler Partners to Present at USLAW Virtual Retreat
September 21, 2020 | Commercial Litigation | Professional Liability | Real Estate, Zoning & Land Use | Compliance Investigations & White Collar | Appeals | Bankruptcy | Directors & Officers Liability | Employment & Labor | General Liability | Intellectual Property | Corporate
Uniondale, New York – September 2020 – Six attorneys from Rivkin Radler will be speakers at USLAW Network’s virtual retreat, which takes place September 30 through October 9. The retreat is intended for general counsel, in-house counsel, heads and managers of claims and risk, C-suite executives, and other legal decision makers. The program will cover …
Read More
Bank, Bholan and Kaiser Secure Pre-answer Dismissal
September 17, 2020 | Compliance Investigations & White Collar
Brian Bank, Michelle Bholan and Geoffrey Kaiser secured pre-answer dismissal of various False Claims Act claims brought against three New York nephrologists by a relator, also a nephrologist. The action, which the relator brought on behalf of the United States of America under the False Claims Act’s qui tam provisions, alleged two theories against the …
Read More
Kaiser Quoted in Part B News
August 27, 2020 | Compliance Investigations & White Collar
Jeff Kaiser was quoted in Part B News, “Do Stark waivers cover your rent break? Only if the break meets ‘COVID-19 purposes.” The article discusses the new Stark Law waivers issued due to the COVID-19 pandemic. One waiver in particular covers rental arrangements that are under fair market value (FMV) which are normally forbidden under …
Read More
Ullman Quoted on FDA Import Alert Request
August 4, 2020 | Compliance Investigations & White Collar
Marc Ullman was interviewed for the Natural Products Insider article, “FDA, supplement manufacturer debate NDI import alert request.” The article discusses why the FDA should issue an import alert on beta-alanine ingredients manufactured in China. To read the full article, click here. …
Read More
Next Page

Get legal updates and news delivered to your inbox